Hikma Pharmaceuticals (OTCMKTS:HKMPY) Trading Up 2.9% – What’s Next?

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY)’s stock price traded up 2.9% on Tuesday . The stock traded as high as $37.25 and last traded at $36.38. 1,188 shares changed hands during trading, a decline of 33% from the average session volume of 1,763 shares. The stock had previously closed at $35.35.

Hikma Pharmaceuticals Price Performance

The stock has a 50-day moving average of $37.03 and a 200-day moving average of $41.43.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.